Researchers in Germany believe that MR imaging should be included among the World Health Organization’s options for diagnosing sporadic Creutzfeldt-Jakob disease (sCJD), which is associated with exposure to mad cow disease.
Researchers in Germany believe that MR imaging should be included among the World Health Organization's options for diagnosing sporadic Creutzfeldt-Jakob disease (sCJD), which is associated with exposure to mad cow disease.
Principal investigator Dr. Henriette Tschampa and colleagues at the Clinical University of Bonn enrolled 193 consecutive patients suspected of having the condition. All the patients had previously been examined by a neurologist from the German CJD Surveillance Unit in a study that took place between 1999 and 2002.
In addition to evaluating MRI's utility, the investigators paired study results with those of electroencephalography and 14-3-3 protein analysis. They found that MR provided a reliable diagnosis of sCJD.
In 442 scans, MR's sensitivity and specificity were nearly 70% and 85%, respectively, in patients with a clinical or postmortem sCJD diagnosis. Sensitivity and specificity for EEG and 14-3-3 protein analysis were 32% and 94%, and 91% and 44%, respectively.
MR's imaging protocol included T2-weighted, FLAIR, diffusion-weighted, and proton density-weighted sequences. Three independent observers compared and rated the studies and reached high agreement.
Even though MR's interpretation could require some effort, it provides useful information that could narrow down an sCJD diagnosis, it is 100% noninvasive, and it has an edge over diagnostic alternatives plagued by high false-positive rates. MRI is not among WHO's sanctioned diagnostic tests for sCJD, but the time to incorporate it has come, Tschampa said.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
Possible Real-Time Adaptive Approach to Breast MRI Suggests ‘New Era’ of AI-Directed MRI
June 3rd 2025Assessing the simulated use of AI-generated suspicion scores for determining whether one should continue with full MRI or shift to an abbreviated MRI, the authors of a new study noted comparable sensitivity, specificity, and positive predictive value for biopsies between the MRI approaches.